Common use of Terms Defined Elsewhere Clause in Contracts

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “401(k) Plan” Section 6.12 “After Consultation” Section 5.2(b) “Agreement” Introduction “Appointment Date” Section 5.1 “Appointment Time” Section 1.3 “Appraisal Rights” Section 2.3(a) “Assignee” Section 9.13 “Balance Sheet Date” Section 3.8(a) “Bankruptcy Claims/Interest Section 3.25(b) “Bankruptcy Confirmation Order” Section 3.25 “Base Premium” Section 6.6(d) “Benefit Plans” Section 3.11(a) “Certificate of Merger” Section 1.5 “Certificates” Section 2.2(b) “Closing” Section 1.6 “Closing Date” Section 1.6 “Code” Section 2.2(e) “Common Stock” Section 3.2(a) “Company” Introduction “Company Agreements” Section 3.5(a) “Company Board of Directors” Recitals “Company Bylaws” Section 1.3(b) “Company Certificate” Section 1.3(b) “Company Change in Recommendation” Section 5.3(b) “Company Collective Bargaining Agreement” Section 3.16(a) “Company Disclosure Schedule” Article III “Company Financial Advisor” Section 3.20 “Company Governing Documents” Section 1.3(b) “Company IP Agreements” Section 3.15(d) “Company Material Contract” Section 3.13 “Company Options” Section 2.5(a) “Company Permits” Section 3.17(b) “Company Recommendation” Section 5.3(a) “Company Rights” Section 3.2(a) “Company Rights Agreement” Section 3.2(a) “Company Scheduled Agreements” Section 3.5(a) “Company SEC Documents” Section 3.6(a)

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “401(k) 2004 Incentive Plan” Section 6.12 6.10(f) “After ConsultationAffiliate Agreement” Section 5.2(b) Recitals “Agreement” Introduction Preamble “Appointment Antitrust Filing” Section 6.5(b) “Balance Sheet” Section 3.10(c) “Benefits Date” Section 5.1 6.10(b) “Appointment TimeCertificate” Section 1.3 “Appraisal Rights” Section 2.3(a) “Assignee” Section 9.13 “Balance Sheet Date” Section 3.8(a) “Bankruptcy Claims/Interest Section 3.25(b) “Bankruptcy Confirmation Order” Section 3.25 “Base Premium” Section 6.6(d) “Benefit Plans” Section 3.11(a2.1(a)(i) “Certificate of Merger” Section 1.5 1.2 “CertificatesChange of Recommendation” Section 2.2(b6.4(e) “Closing” Section 1.6 1.2 “Closing Date” Section 1.6 1.2 “Code” Section 2.2(e) “Common Stock” Section 3.2(a) Recitals “Company” Introduction Preamble “Company AgreementsBenefit Plan” Section 3.5(a) “Company Board of Directors” Recitals 3.10 “Company Bylaws” Section 1.3(b) 3.3 “Company Certificate” Section 1.3(b) 3.3 “Company Change in RecommendationCommon Stock” Section 5.3(b) “Company Collective Bargaining Agreement” Section 3.16(a2.1(a)(i) “Company Disclosure ScheduleLetter” Article III 3 “Company Financial Advisor” Section 3.20 3.23 “Company Governing DocumentsForm 10-K” Section 1.3(b) “Company IP Agreements” Section 3.15(d) 3.3 “Company Material Contract” Section 3.13 “Company OptionsPension Plans” Section 2.5(a3.10(a) “Company Permits” Section 3.17(b3.7 “Company Preferred Stock” Section 3.4(a) “Company Recommendation” Section 5.3(a) “Company Rights” Section 3.2(a6.1(c) “Company Rights Agreement” Section 3.2(a) “Company Scheduled Agreements” Section 3.5(a2.1(c)(ii) “Company SEC DocumentsFilings” Section 3.6(a)3.8(a) “Company Stockholder Approval” Section 3.24 “Company Stockholders’ Meeting” Section 6.2 “Company Subsidiaries” Section 3.1 “Company Welfare Plans” Section 3.10(a) “Confidentiality Agreement” Section 6.3(b) “Continuation Period” Section 6.10(b) “DGCL” Recitals “Effective Time” Section 1.2 “Employment Agreements” Recitals “ERISA Affiliate” Section 3.10(a) “ESPP” Section 2.5 “Exchange Agent” Section 2.2(a) “Exchange Fund” Section 2.2(a) “FDA” Section 3.7 “FDCA” Section 3.7 “Former Superior Proposal” Section 6.4(d) “HMO” Section 3.10(i) “LLC Act” Recitals “Merger” Recitals “Merger Consideration” Section 2.1(a)(i) “Merger Sub” Preamble “Offering Memorandum” Section 3.30 “Outside Date” Section 8.1(b) “Owned Real Properties” Section 3.20(b) “Parent” Preamble “Parent Bylaws” Section 4.2 “Parent Certificate” Section 4.2 “Parent Plans” Section 6.10(c) “Parent Rights Agreement” Section 2.1(c)(i) “Parent SEC Filings” Section 4.6(a) “Parent Subsidiary” Section 4.9 “Proxy Statement” Section 6.1(a) “Registration Statement” Section 6.1(a) “Regulatory Conditions” Section 8.1(b) “Representatives” Section 6.3(a) “▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act” Section 3.26 “Section 16” Section 6.19 “Stock Purchase Agreement” Section 6.15 “Superior Proposal Notice” Section 6.4(c) “Surviving Entity” Section 1.1 “Termination Fee” Section 8.2(e)(i) “Transition Assistance Plans” Section 2.4 “UK Stock Option Plans” Section 2.4 “VEBAs” Section 3.10(a) “Voting Agreements” Recitals

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “401(kAction Section 4.13 Agreement Introduction Alternative Acquisition Agreement Section 6.4(b)(iii) Plan” Alternative Financing Section 6.12 “After Consultation” 6.6(b) Alternative Financing Commitment Section 5.2(b6.6(b) “Agreement” Introduction “Appointment Date” Antitrust Laws Section 5.1 “Appointment Time” 4.4(b) Capped Damages Section 1.3 “Appraisal Rights” Section 2.3(a8.2(a)(ii) “Assignee” Section 9.13 “Balance Sheet Date” Section 3.8(a) “Bankruptcy Claims/Interest Section 3.25(b) “Bankruptcy Confirmation Order” Section 3.25 “Base Premium” Section 6.6(d) “Benefit Plans” Section 3.11(a) “Certificate of Merger” Merger Section 1.5 “Certificates” 2.3 Certificates Section 2.2(b3.2(b), Section 3.2(b) “Closing” CFIUS Section 1.6 “4.4(b) Change of Recommendation Notice Section 6.4(e)(i) Closing Date” Section 1.6 “Code” 2.2 Closing Date Section 2.2(e2.2 COBRA Section 4.10(i) “Common Stock” Company Introduction Company Adverse Recommendation Change Section 6.4(d)(i) Company Financial Advisor Section 4.21 Company Financial Statements Section 4.6(b) Company Group Section 8.2(b)(v) Company Insurance Policies Section 4.17 Company Material Contract Section 4.12(a) Company Preferred Stock Section 4.2(a) Company Recommendation Section 4.3(b) Company Representatives Section 6.3(a) Company SEC Filings Section 4.6(a) Company Stock Rights Section 4.2(c) Company Stockholders Meeting Section 6.2(d) Company Subsidiary Section 4.1(a) Condemnation Actions Section 4.18(d) Cut-Off Date Section 6.4(b)(vi) D&O Insurance Section 6.12(b) Debt Commitment Letters Section 5.6(a) Debt Financing Section 5.6(a) DGCL Recitals Dissenting Shares Section 3.3 Effective Time Section 2.3 End Date Section 8.1(b)(i) Enforcement Exceptions Section 4.3(a) Equity Commitment Letter Section 5.6(a) Equity Financing Section 5.6(a) Exchange Fund Section 3.2(a) “Company” Existing Debt Section 4.2(h) Exon-▇▇▇▇▇▇ Section 4.4(b) FCPA Section 4.27 Financing Section 5.6(a) Financing Commitments Section 5.6(a) Guarantee Recitals Guarantor Recitals Leased Real Property Section 4.18(a) Liability Section 4.7 Merger Recitals Merger Consideration Section 3.1(a) Merger Sub Introduction “Company Agreements” NDA Consent Section 3.5(a6.5(e) “Company Board of Directors” Recitals “Company Bylaws” New Plans Section 1.3(b6.10(c) “Company Certificate” NRC Consents Section 1.3(b4.4(b) “Company Change in Recommendation” Option Cash Payment Section 5.3(b3.5(b) “Company Collective Bargaining Agreement” Original Date Section 3.16(a6.2(e) “Company Disclosure Schedule” Article III “Company Financial Advisor” Owned Real Property Section 3.20 “Company Governing Documents” 4.18(a) Parent Introduction Parent Group Section 1.3(b8.2(c)(iii) “Company IP Agreements” Parent Representatives Section 3.15(d6.3(a) “Company Material Contract” Section 3.13 “Company Options” Section 2.5(a) “Company Permits” Section 3.17(b) “Company Recommendation” Section 5.3(a) “Company Rights” Parties Introduction Party Introduction Paying Agent Section 3.2(a) “Performance-Based Company Rights Agreement” Phantom Share Award Section 3.2(a3.5(d) “Company Scheduled Agreements” Present Fair Salable Value Section 3.5(a5.11 Proxy Statement Section 4.20 Real Property Section 4.18(a) “Company SEC Documents” Real Property Leases Section 3.6(a)4.18(a) Required Financial Information Section 6.7(a) Restricted Stock Payment Section 3.5(c) Solicitation Period End Date Section 6.4(a) Solvent Section 5.11 Stockholder Approval Section 4.23 Surviving Corporation Section 2.1 Takeover Statute Section 4.19 Transaction Litigation Section 6.8

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “401(k) PlanAgreement” Preamble “Alternative Acquisition Agreement” Section 6.12 “After Consultation” Section 5.2(b) “Agreement” Introduction “Appointment Date” Section 5.1 “Appointment Time” Section 1.3 “Appraisal Rights” Section 2.3(a) “Assignee” Section 9.13 “Balance Sheet Date” Section 3.8(a5.5(d) “Bankruptcy Claims/Interest Section 3.25(b) “Bankruptcy Confirmation Orderand Equitable Exceptions” Section 3.25 “Base Premium” Section 6.6(d) “Benefit Plans” Section 3.11(a3.3(a) “Certificate of Merger” Section 1.5 1.3 “Certificates” Section 2.2(b) “Change of Board Recommendation” Section 5.5(d) “Claim” Section 5.10(a) “Closing” Section 1.6 1.2 “Closing Date” Section 1.6 1.2 “CodeCommon Shares” Section 2.2(e2.1(a) “Common StockShare Merger Consideration” Section 3.2(a2.1(a) “Company” Introduction Preamble “Company AgreementsBenefit Plan” Section 3.5(a3.12(a) “Company Board” Section 3.3(b) “Company Board of DirectorsRecommendation” Recitals Section 5.2(c) “Company Bylaws” Section 1.3(b3.1(b) “Company Certificate” Section 1.3(b) “Company Change in Recommendation” Section 5.3(b) “Company Collective Bargaining Agreement” Section 3.16(a3.1(b) “Company Disclosure Schedule” Article III 3 “Company Financial Advisor” Section 3.20 3.22 “Company Governing DocumentsFinancial Statements” Section 1.3(b3.8(c) “Company IP AgreementsIntellectual Property” Section 3.15(d3.17(b) “Company Material Contract” Section 3.13 3.14(a) “Company Options” Section 2.5(a) 2.3 “Company Permits” Section 3.17(b3.7(a) “Company RecommendationRepresentatives” Section 5.3(a) “Company Rights” Section 3.2(a5.4(a) “Company Rights Agreement” Section 3.2(a3.3(b) “Company Scheduled AgreementsRights Agreement Amendment” Section 3.5(a3.3(b) “Company SEC Documents” Section 3.6(a3.8(a) “Company Stock Option Plans” Section 2.3 “Company Stockholder Approval” Section 3.4 “Confidentiality Agreement” Section 5.4(b) “Continuing Employees” Section 5.9(a) “D&O Insurance” Section 5.10(b) “DGCL” Section 1.1 “Dissenting Shares” Section 2.1(f)(i) “Effective Time” Section 1.3 “ERISA” Section 3.12(a)

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “401(k) PlanAffected Employees” Section 6.12 “After Consultation” Section 5.2(b6.8(a) “Agreement” Introduction “Appointment Date” Section 5.1 “Appointment Time” Section 1.3 Preamble “Appraisal Rights” Section 2.3(a) “Assignee” Section 9.13 “Balance Sheet Date” Section 3.8(a) “Bankruptcy Claims/Interest Section 3.25(b) “Bankruptcy Confirmation Order” Section 3.25 “Base Premium” Section 6.6(d6.5(d) “Benefit PlansBook-Entry Shares” Section 3.11(a2.2(b) “Certificate of Merger” Section 1.5 1.3 “Certificates” Section 2.2(b) “Change in Control Agreements” Section 6.8(d) “Change of Recommendation” Section 5.2(a) “Closing” Section 1.6 1.2 “Closing Date” Section 1.6 “Code” Section 2.2(e) 1.2 “Common Stock” Section 3.2(a) “Company” Introduction “Company Agreements” Section 3.5(a) Preamble “Company Board of Directors” Recitals “Company BylawsBoard Recommendation” Recitals “Company Disclosure Letter” Article III “Company Equity Awards” Section 1.3(b2.4(c) “Company CertificateEquity Plan” Section 1.3(b2.4(a) “Company Change in Recommendation” Section 5.3(b) “Company Collective Bargaining Agreement” Section 3.16(a) “Company Disclosure Schedule” Article III “Company Financial Advisor” Section 3.20 “Company Governing Documents” Section 1.3(b) “Company IP Agreements” Section 3.15(d) “Company Material Contract” Section 3.13 “Company Options” Section 2.5(a2.4(a) “Company Permits” Section 3.17(b) “Company Recommendation” Section 5.3(a) “Company Rights” Section 3.2(a) “Company Rights Agreement” Section 3.2(a) “Company Scheduled Agreements” Section 3.5(a3.18(b) “Company SEC Documents” Section 3.6(a)3.6 “Covered Persons” Section 6.5(b) “Debt Commitment Letter” Section 4.7 “DGCL” Recitals “Dissenting Shares” Section 2.3(a) “Effective Time” Section 1.3 “Equity Interests” Section 3.2(b) “Exchange Act” Section 1.6 “Exchange Fund” Section 2.2(a) “FCPA” Section 3.25 “Financial Statements” Section 3.6 “GAAP” Section 3.6 “Governmental Consents” Section 6.3(a) “Governmental Entity” Section 3.5 “HSR Act” Section 3.5 “Indemnification Agreements” Section 6.5(a) “Leases” Section 3.11(b) “Leased Real Property” Section 3.11(b) “Legal Proceeding” Section 3.13 “Match Period” Section 5.2(d) “Merger” Recitals “Merger Consideration” Recitals “Notice of Superior Proposal or Intervening Event” Section 5.2(d) “Offer” Recitals “Option Consideration” Section 2.4(a) “Outside Date” Section 8.1(c) “Owned Intellectual Property” Section 3.12(a) “Owned Real Property” Section 3.11(a) “Parent” Preamble “Parent Disclosure Letter” Article IV “Paying Agent” Section 2.2(a) “Permitted Liens” Section 3.11(a) “Preferred Stock” Section 3.2(a) “Proxy Statement” Section 1.6(a) “Purchaser” Preamble “Purchaser Common Stock” Section 2.1 “Regulatory Law” Section 6.3(e) “Regulatory Material Adverse Effect” Section 6.3(c) “Requisite Stockholder Approval” Section 3.21 “Restricted Share” Section 2.4(b) “Reverse Termination Fee” Section 8.2(c) “▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act” Section 3.6 “SEC” Section 1.6 “Securities Act” Section 3.6 “Settlement Action” Section 6.3(c) “Shares” Recitals

Terms Defined Elsewhere. The following is a list of additional terms are defined elsewhere used in this Agreement, as indicated belowAgreement and a reference to the Section hereof in which such term is defined: “401(kAcquisition Proposal Section 7.7(a) Plan” ARRA Section 4.11(g) Audited Financial Statements Section 6.13 Auditor’s Consent Section 6.13 Bankruptcy and Equity Exception Section 4.2(a) Buyer Preamble Business Software Section 4.13(i) Buyer Indemnitees Section 12.2(a) Cap Section 12.3(c)(i) Calculation Notice Section 3.2(b) Change In Control Customer Contracts Section 4.14(d) Closing Section 9.1 Closing Date Section 9.1 Closing Date Interest Rate Section 3.2(d) CMS Preamble CMS Group Charter Documents Section 4.1(b) CMS Group Release Section 7.8 COBRA Section 4.11(g) Coventry Preamble Cure Period Section 11.1(b) Deductible Section 12.3(a) Disputed Items Section 3.2(b) D&O Obligations Section 6.12 “After Consultation” D&O Released Parties Section 5.2(b12.6 Excluded Assets Section 2.2(a) “Agreement” Introduction “Appointment Date” Section 5.1 “Appointment Time” Section 1.3 “Appraisal Rights” Section 2.3(a) “Assignee” Section 9.13 “FHC Recitals FHC Stock Recitals FHS Recitals FHS Closing Date Balance Sheet Date” Section 3.8(a) “Bankruptcy Claims/Interest Section 3.25(b) “Bankruptcy Confirmation Order” Section 3.25 “Base Premium” Section 6.6(d) “Benefit Plans” Section 3.11(a) “Certificate of Merger” Section 1.5 “Certificates” Section 2.2(b) “Closing” Section 1.6 “Closing Date” Section 1.6 “Code” Section 2.2(e) “Common Stock” Section 3.2(a) “Company” Introduction “Company Agreements” FHS Closing Date Payment Section 3.5(a2.4(a) “Company Board of Directors” Recitals “Company Bylaws” FHS Estimated Working Capital Section 1.3(b3.1(a) “Company Certificate” FHS Financial Statements Section 1.3(b4.5(a) “Company Change in Recommendation” Section 5.3(b) “Company Collective Bargaining Agreement” Section 3.16(a) “Company Disclosure Schedule” Article III “Company Financial Advisor” Section 3.20 “Company Governing Documents” Section 1.3(b) “Company IP Agreements” Section 3.15(d) “Company Material Contract” Section 3.13 “Company Options” Section 2.5(a) “Company Permits” Section 3.17(b) “Company Recommendation” Section 5.3(a) “Company Rights” FHS Initial Calculation Section 3.2(a) “Company Rights Agreement” FHS Interim Financial Statements Section 3.2(a4.5(a) “Company Scheduled Agreements” FHS Material Permits Section 3.5(a4.17 FHS Negative Estimated Working Capital Adjustment Section 3.1(a) “Company SEC Documents” FHS Positive Estimated Working Capital Adjustment Section 3.6(a)3.1(a) FHS Restricted Business Section 7.3(a) FHS Stock Recitals FHS Working Capital Adjustment Amount Section 3.2(d) FHS Year End Financial Statements Section 4.5(a) Final FHS Working Capital Section 3.2(d) FIRPTA Affidavit Section 9.2(l) First Health Group Preamble Foreign Plans Section 4.11(h) Fundamental Representations Section 12.1(a) Governmental Damages Section 10.2(e) Governmental Investigation Section 10.2(e) HIPAA Section 4.11(g) Hired Employees Section 7.2(b)(i) HSR Filing Section 6.5(b) Indemnifiable Losses Section 12.2(b) Indemnification Notice Section 12.5(a) Indemnified Party Section 12.2(c) Infringes Section 4.13(b) Injunctions Section 10.1(b) Labor Union Section 4.12(a) Legal Actions Section 10.1(c) Loss of Profits Section 12.3(f) Material Contract Section 4.14(b) Party or Parties Preamble Policies Section 4.15 Property Taxes Section 8.2(b)(i) Provider Synergies Recitals Provider Synergies Interests Recitals Purchase Price Section 2.4(a) Re-Calculated FHS Working Capital Section 3.2(e) Re-Calculated FHS Working Capital Adjustment Amount Section 3.2(e) Registered IP Section 4.13(a) Related Persons Section 4.19 Releasing Parties Section 12.6 Restraints Section 10.1(c) Seller Indemnifiable Losses Section 12.2(b) Seller Indemnitees Section 12.2(b) Settlement Firm Section 3.2(c) Shares Recitals Tax Claim Section 8.3(a) Tax Return Notice Section 8.1(b)(i) Tax Settlement Firm Section 8.1(b)(i) Termination Date Section 11.1(e)(i) Third Party Claim Section 12.4(a) Transfer Taxes Section 8.2(a) Unsold Securities Section 7.9

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “401(k) 2004 Incentive Plan” Section 6.12 6.10(f) “After ConsultationAffiliate Agreement” Section 5.2(b) Recitals “Agreement” Introduction Preamble “Appointment Antitrust Filing” Section 6.5(b) “Balance Sheet” Section 3.10(c) “Benefits Date” Section 5.1 6.10(b) “Appointment TimeCertificate” Section 1.3 “Appraisal Rights” Section 2.3(a) “Assignee” Section 9.13 “Balance Sheet Date” Section 3.8(a) “Bankruptcy Claims/Interest Section 3.25(b) “Bankruptcy Confirmation Order” Section 3.25 “Base Premium” Section 6.6(d) “Benefit Plans” Section 3.11(a2.1(a)(i) “Certificate of Merger” Section 1.5 1.2 “CertificatesChange of Recommendation” Section 2.2(b6.4(e) “Closing” Section 1.6 1.2 “Closing Date” Section 1.6 1.2 “Code” Section 2.2(e) “Common Stock” Section 3.2(a) Recitals “Company” Introduction Preamble “Company AgreementsBenefit Plan” Section 3.5(a) “Company Board of Directors” Recitals 3.10 “Company Bylaws” Section 1.3(b) 3.3 “Company Certificate” Section 1.3(b) 3.3 “Company Change in RecommendationCommon Stock” Section 5.3(b) “Company Collective Bargaining Agreement” Section 3.16(a2.1(a)(i) “Company Disclosure ScheduleLetter” Article III 3 “Company Financial Advisor” Section 3.20 3.23 “Company Governing DocumentsForm 10-K” Section 1.3(b) “Company IP Agreements” Section 3.15(d) 3.3 “Company Material Contract” Section 3.13 “Company OptionsPension Plans” Section 2.5(a3.10(a) “Company Permits” Section 3.17(b3.7 “Company Preferred Stock” Section 3.4(a) “Company Recommendation” Section 5.3(a) “Company Rights” Section 3.2(a6.1(c) “Company Rights Agreement” Section 3.2(a) “Company Scheduled Agreements” Section 3.5(a2.1(c)(ii) “Company SEC DocumentsFilings” Section 3.6(a)3.8(a) “Company Stockholder Approval” Section 3.24 “Company Stockholders’ Meeting” Section 6.2 “Company Subsidiaries” Section 3.1 “Company Welfare Plans” Section 3.10(a) “Confidentiality Agreement” Section 6.3(b) “Continuation Period” Section 6.10(b) “DGCL” Recitals “Effective Time” Section 1.2 “Employment Agreements” Recitals “ERISA Affiliate” Section 3.10(a) “ESPP” Section 2.5 “Exchange Agent” Section 2.2(a) “Exchange Fund” Section 2.2(a) “FDA” Section 3.7 “FDCA” Section 3.7 “Former Superior Proposal” Section 6.4(d) “HMO” Section 3.10(i) Table of Contents “LLC Act” Recitals “Merger” Recitals “Merger Consideration” Section 2.1(a)(i) “Merger Sub” Preamble “Offering Memorandum” Section 3.30 “Outside Date” Section 8.1(b) “Owned Real Properties” Section 3.20(b) “Parent” Preamble “Parent Bylaws” Section 4.2 “Parent Certificate” Section 4.2 “Parent Plans” Section 6.10(c) “Parent Rights Agreement” Section 2.1(c)(i) “Parent SEC Filings” Section 4.6(a) “Parent Subsidiary” Section 4.9 “Proxy Statement” Section 6.1(a) “Registration Statement” Section 6.1(a) “Regulatory Conditions” Section 8.1(b) “Representatives” Section 6.3(a) “▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act” Section 3.26 “Section 16” Section 6.19 “Stock Purchase Agreement” Section 6.15 “Superior Proposal Notice” Section 6.4(c) “Surviving Entity” Section 1.1 “Termination Fee” Section 8.2(e)(i) “Transition Assistance Plans” Section 2.4 “UK Stock Option Plans” Section 2.4 “VEBAs” Section 3.10(a) “Voting Agreements” Recitals

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “401(k) PlanAdjustment” Section 6.12 “After Consultation” Section 5.2(b2.1(f) “Agreement” Introduction Preamble “Appointment DateAlternative Acquisition Agreement” Section 5.1 5.4(d) “Appointment TimeAlternative Financing” Section 1.3 “Appraisal Rights” Section 2.3(a5.13(c) “Assignee” Section 9.13 “Balance Sheet Date” Section 3.8(a) “Bankruptcy Claims/Interest Section 3.25(b) “Bankruptcy Confirmation Order” Section 3.25 “Base Premium” Section 6.6(d) “Benefit Plans” Section 3.11(a) “Certificate Articles of Merger” Section 1.5 1.2 “CertificatesBenefit Protection Period” Section 5.9(a) “Book-Entry Shares” Section 2.2(b) “Cash Consideration” Section 2.1(a) “Certificate” Section 2.1(b) “Change of Company Board Recommendation” Section 5.4(a) “Change of Parent Board Recommendation” Section 5.2(e) “Closing” Section 1.6 1.2 “Closing Date” Section 1.6 1.2 “CodeCommitment Letter” Section 2.2(e4.18(b) “Company” Preamble “Company Benefit Plan” Section 3.12(a) “Company Board” Recitals “Company Board Recommendation” Section 5.2(d) “Company Bylaws” Section 3.1(b) “Company Charter” Section 3.1(b) “Company Common Stock” Section 3.2(a) “CompanyCompany Designee” Introduction Section 5.20 “Company AgreementsDisclosure Letter” Article 3 “Company Employees” Section 3.5(a5.9(a) “Company Board of Directors” Recitals “Company BylawsEquity Plans” Section 1.3(b2.4(a) “Company CertificateFinancial Statements” Section 1.3(b3.7(b) “Company Change in RecommendationInsurance Policies” Section 5.3(b3.22 “Company Leased Real Property” Section 3.16(b) “Company Collective Bargaining AgreementOptions” Section 2.4(a) “Company Owned Real Property” Section 3.16(a) “Company Disclosure Schedule” Article III “Company Financial AdvisorPermits” Section 3.20 “Company Governing Documents” Section 1.3(b3.6(a) “Company IP AgreementsPreference Stock” Section 3.15(d3.2(a) “Company Material ContractPreferred Stock” Section 3.13 “Company Options” Section 2.5(a3.2(a) “Company PermitsReal Property” Section 3.17(b3.16(c) “Company RecommendationReal Property Lease” Section 3.16(b) “Company Real Property Rights” Section 3.16(c) “Company Representatives” Section 5.3(a) “Company RightsRequired Governmental Approvals” Section 3.2(a) “Company Rights Agreement” Section 3.2(a) 3.5 “Company Scheduled AgreementsContract” Section 3.5(a3.14(b) “Company SEC Documents” Section 3.6(a3.7(a) “Company Shareholder Approval” Section 3.3(c) “Company Subsidiary” Section 3.1(c) “Company Tax Certificates” Section 5.18(d) “Company Termination Fee” Section 7.2(b)(i) “Company Trading Guidelines” Section 3.24 “Confidentiality Agreements” Section 5.3(c) “CPUC” Section 3.5(c) “D&O Insurance” Section 5.11(b)

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “401(k) PlanAFFILIATE” Section 6.12 3.18 “After ConsultationAFFILIATE TRANSACTION” Section 5.2(b3.18 “AGREEMENT” Preamble “ARTICLES OF MERGER” Section 1.3(a) “Agreement” Introduction “Appointment DateBREAK-UP FEE” Section 5.1 8.2(b) “Appointment TimeCERCLA” Section 1.3 3.12 “Appraisal Rights” Section 2.3(a) “Assignee” Section 9.13 “Balance Sheet Date” Section 3.8(a) “Bankruptcy Claims/Interest Section 3.25(b) “Bankruptcy Confirmation Order” Section 3.25 “Base Premium” Section 6.6(d) “Benefit Plans” Section 3.11(a) “Certificate of Merger” Section 1.5 “CertificatesCERTIFICATE” Section 2.2(b) “ClosingCLAIM” Section 1.6 6.5(b) “Closing DateCLOSING” Section 1.6 1.4 “CodeCLOSING DATE” Section 2.2(e) 1.4 “Common StockCOMPANY” Section 3.2(a) Preamble “Company” Introduction “Company Agreements” Section 3.5(a) “Company Board of DirectorsCOMPANY BOARD” Recitals “Company BylawsCOMPANY BYLAWS” Section 1.3(b1.2(b) “Company CertificateCOMPANY COMMON SHARES” Recitals “COMPANY COMMON SHARE MERGER “CONSIDERATION” Section 1.3(b2.1(b) “Company Change in RecommendationCOMPANY DECLARATION OF TRUST” Section 5.3(b1.2(a) “Company Collective Bargaining Agreement” Section 3.16(a) “Company Disclosure ScheduleCOMPANY DISCLOSURE SCHEDULE” Article III “Company Financial AdvisorCOMPANY EMPLOYEES” Section 6.8(a) “COMPANY ENVIRONMENTAL PERMITS” Section 3.12 “COMPANY FILED SEC REPORTS” Section 3.5 “COMPANY INTELLECTUAL PROPERTY RIGHTS” Section 3.20 “Company Governing DocumentsCOMPANY LEASE” Section 1.3(b3.9(h) “Company IP AgreementsCOMPANY MATERIAL ADVERSE EFFECT” Section 3.15(d3.1(a) “Company Material ContractCOMPANY PERMITS” Section 3.13 3.25(a) “Company OptionsCOMPANY PROPERTY” Section 2.5(a3.9(a) “Company PermitsCOMPANY RECOMMENDATION” Section 3.17(b6.1(c) “Company RecommendationCOMPANY RESTRICTED SHARES” Section 5.3(a2.1(h) “Company RightsCOMPANY RSEs” Section 3.2(a2.1(g) “Company Rights AgreementCOMPANY SEC REPORTS” Section 3.2(a3.4(a) “Company Scheduled AgreementsCOMPANY SHARE OPTION” Section 3.5(a2.1(f) “Company SEC DocumentsCOMPANY SHARE BENEFIT PLANS” Section 3.6(a)2.1(f) “COMPANY SHARE RIGHTS” Section 3.2(c) “COMPANY SHAREHOLDER APPROVAL” Section 3.3(b) “COMPANY SHAREHOLDERS MEETING” Section 6.1(c) “COMPANY SUBSIDIARY” Section 3.1(b) “COMPANY TITLE INSURANCE POLICY” Section 3.9(c) “CONFIDENTIALITY AGREEMENT” Section 6.6(b) “CORPORATE BUDGET” Section 5.1